aibioILMN ILLUMINA, INC.
ILLUMINA, INC. (ILMN) news
ILLUMINA, INC. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker ILMN, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.
Latest ILLUMINA, INC. news
We have not published a story on ILLUMINA, INC. yet. When there is news, it will appear here.
ILLUMINA, INC. annual financials
| Line | FY ended Dec 28, 2025 | FY ended Dec 29, 2024 |
|---|---|---|
| Revenue | $4.34 billion | $4.37 billion |
| Research and development | $967.0 million | $1.17 billion |
| Net income (loss) | $850.0 million | -$1.22 billion |
| Cash from operations | $1.08 billion | $837.0 million |
| Cash and equivalents | $1.42 billion | $1.13 billion |
| Short-term investments | $215.0 million | $93.0 million |
Questions about ILLUMINA, INC.
What is the ticker symbol of ILLUMINA, INC.?
ILLUMINA, INC. trades under the ticker ILMN on NASDAQ.
Where is ILLUMINA, INC. listed?
ILLUMINA, INC. is listed on NASDAQ.
Which country or territory is ILLUMINA, INC. listed under?
Our directory records ILLUMINA, INC. under United States.
Does aibio.space cover ILLUMINA, INC.?
aibio.space lists ILLUMINA, INC. among 2,820 public biotech companies and publishes its news here as stories appear.
What was ILLUMINA, INC.'s revenue last year?
$4.34 billion for the fiscal year ended Dec 28, 2025, as reported to the SEC.
Is ILLUMINA, INC. profitable?
ILLUMINA, INC. reported net income of $850.0 million for the fiscal year ended Dec 28, 2025, and generated $1.08 billion of cash from operations, per its annual report to the SEC.
How much does ILLUMINA, INC. spend on research and development?
$967.0 million in the fiscal year ended Dec 28, 2025, per its annual report.
How much cash does ILLUMINA, INC. have?
$1.34 billion in cash and short-term investments at Sep 27, 2026, per its 10-Q.
Investor discussion: ILLUMINA, INC.
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Capital-markets timeline
- Legal
Disclosed a shareholder lawsuit, subpoena or other legal matter. SEC Form 8-K (Items 8.01,9.01). Source
Stock chart
Listing details
- Company
- ILLUMINA, INC.
- Ticker
- ILMN
- Listing
- NASDAQ
- Country or territory
- United States
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction